We are live on !
Find out more
AlphaMark Advisors Portfolio holdings
AUM
$231M
Turnover
25.87%
1-Year Est. Return
19.98%
This Fund
S&P 500
This Quarter Est. Return
-0.21%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$231M
AUM Growth
-$58.7M
(-20%)
Cap. Flow
-$55.9M
Cap. Flow % of AUM
Cap. Flow %
-24.18%
Top 10 Holdings %
Top 10 Hldgs %
38.54%
Holding
773
New
68
Increased
169
Reduced
108
Closed
132
Avg Time Held
4.2
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.09M |
| 2 |
Regan Floating Rate MBS ETF
MBSF
|
+$782K |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$761K |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$597K |
| 5 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$591K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AlphaMark Actively Managed Small Cap ETF
SMCP
|
+$29.4M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$639K |
| 3 |
Lumen Technologies, Inc. Common Stock
LUMN
|
+$547K |
| 4 |
IBM
IBM
|
+$539K |
| 5 |
Corcept Therapeutics
CORT
|
+$489K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 62.58% |
| 2 | Technology | 7.52% |
| 3 | Consumer Staples | 5.65% |
| 4 | Financials | 5.28% |
| 5 | Healthcare | 5.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
FT Vest International Equity Buffer ETF September
YSEP
$136M
| $291K | 0.13% |
13,415
-1,000
| -7% | -$22.1K |
2024 Q2
2 quarters
|
|
102
Novo Nordisk
NVO
$181B
| $288K | 0.12% |
3,350
+200
| +6% | +$21.6K |
2013 Q2
46 quarters
|
|
103
State Street SPDR S&P Pharmaceuticals ETF
XPH
$513M
| $285K | 0.12% |
6,640
+415
| +7% | +$18.9K |
2024 Q2
2 quarters
|
|
104
FT Vest International Equity Moderate Buffer ETF December
YDEC
$167M
| $284K | 0.12% |
12,587
+1,050
| +9% | +$24.8K |
2023 Q4
4 quarters
|
|
105
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.58B
| $279K | 0.12% |
5,727
| – | – |
2016 Q4
32 quarters
|
|
106
Pfizer
PFE
$168B
| $278K | 0.12% |
10,468
+8,565
| +450% | +$232K |
2013 Q2
46 quarters
|
|
107
Welltower
WELL
$181B
| $277K | 0.12% |
2,200
-50
| -2% | -$6.56K |
2024 Q3
1 quarter
|
|
108
Stock Yards Bancorp
SYBT
$2.47B
| $268K | 0.12% |
3,748
| – | – |
2022 Q3
9 quarters
|
|
109
Amgen
AMGN
$253B
| $261K | 0.11% |
1,002
+32
| +3% | +$9.49K |
2013 Q2
46 quarters
|
|
110
FT Vest Growth-100 Buffer ETF June
QJUN
$721M
| $261K | 0.11% |
9,300
+111
| +1% | +$3.08K |
2024 Q2
2 quarters
|
|
111
First Trust NASDAQ Cybersecurity ETF
CIBR
$16.7B
| $250K | 0.11% |
3,936
+140
| +4% | +$8.78K |
2022 Q1
11 quarters
|
|
112
Johnson & Johnson
JNJ
$675B
| $250K | 0.11% |
1,729
+361
| +26% | +$55.9K |
2013 Q2
46 quarters
|
|
113
NVIDIA
NVDA
$4.2T
| $247K | 0.11% |
1,843
+490
| +36% | +$67.5K |
2017 Q3
29 quarters
|
|
114
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.49B
| $244K | 0.11% |
4,850
| – | – |
2024 Q1
3 quarters
|
|
115
iShares Core High Dividend ETF
HDV
$16.3B
| $238K | 0.1% |
+10,600
| New | +$249K |
2024 Q4
0 quarters
|
|
116
GE Vernova
GEV
$214B
| $238K | 0.1% |
724
| – | – |
2024 Q2
2 quarters
|
|
117
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.46B
| $237K | 0.1% |
+4,898
| New | +$245K |
2024 Q4
0 quarters
|
|
118
FT Vest Rising Dividend Achievers Target Income ETF
RDVI
$3.89B
| $236K | 0.1% |
9,750
| – | – |
2024 Q1
3 quarters
|
|
119
US Bancorp
USB
$94.6B
| $234K | 0.1% |
4,882
-25
| -0.5% | -$1.23K |
2013 Q2
46 quarters
|
|
120
Corteva
CTVA
$8.1B
| $231K | 0.1% |
4,055
-1,913
| -32% | -$113K |
2023 Q3
5 quarters
|
|
121
Costco
COST
$482B
| $229K | 0.1% |
250
+115
| +85% | +$107K |
2013 Q2
46 quarters
|
|
122
British American Tobacco
BTI
$131B
| $225K | 0.1% |
6,207
+475
| +8% | +$17.2K |
2017 Q3
29 quarters
|
|
123
Southern Company
SO
$109B
| $213K | 0.09% |
2,589
| – | – |
2013 Q2
46 quarters
|
|
124
Fifth Third Bancorp
FITB
$49.2B
| $209K | 0.09% |
4,942
+37
| +0.8% | +$1.66K |
2013 Q2
46 quarters
|
|
125
Truist Financial
TFC
$60.2B
| $209K | 0.09% |
4,818
+24
| +0.5% | +$1.07K |
2015 Q4
36 quarters
|
|
Similar funds
HPFG
GWM
KC
SL
AlphaMark Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, AlphaMark Advisors held 773 positions worth $231M, down 20% from $290M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
AlphaMark Advisors withdrew a net $55.9M in Q4 2024, closing 132 positions and reducing 108 holdings. Its most notable exit was AlphaMark Actively Managed Small Cap ETF, an estimated $29.4M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, up from 58% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, AlphaMark Advisors opened a new position in Toronto Dominion Bank worth $378K.
- AlphaMark Advisors's largest Q4 2024 buy was Toronto Dominion Bank: 7,100 shares worth $378K.
- AlphaMark Advisors added most to State Street Health Care Select Sector SPDR ETF in Q4 2024, an estimated $1.09M increase.
- AlphaMark Advisors's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $639K.
- AlphaMark Advisors fully exited AlphaMark Actively Managed Small Cap ETF in Q4 2024, selling an estimated $29.4M.
- AlphaMark Advisors's ten largest holdings make up 39% of its $231M portfolio in Q4 2024.
- AlphaMark Advisors opened 68 new positions and closed 132 in Q4 2024.
- AlphaMark Advisors's portfolio value fell 20% quarter-over-quarter to $231M.
Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.